Clinical Study
Retreatment of Patients Nonresponsive to Pegylated Interferon and Ribavirin with Daily High-Dose Consensus Interferon
Table 1
Demographics and baseline data.
| Patient Characteristic | Results |
| Ethnicity | | Caucasian | 61.5% | Hispanic | 30.8% | African-American | 7.7% |
| Weight (kilograms) | | Mean ± SEM | | | | Stage 1-2 | 3 | Stage 3 | 5 | Stage 4 | 5 |
| Response to prior treatment () | | Null response | 10 | Partial response | 3 |
| WBC count () | | Mean SEM | | Hemoglobin () | | | | Platelet count () | | | |
|
|
Fibrosis stage defined as modified Ishak score determined as defined by Theise [10].
|